Gordon W C, Prager M D
Cancer Res. 1977 Feb;37(2):507-13.
DNA synthesis by murine lymphoma cells was stimulated up to 20-fold in vitro by syngeneic or allogeneic peritoneal cells (PEC) and peripheral blood lymphocytes, as measured by [3H]thymidine incorporation in a 44-hr assay. The increase in DNA synthesis correlated with an increase in tumor cell number in the cultures. The adherent PEC population was responsible for most of the enhancement. This effect was abrogated by pretreating the adherent cells with the metabolic inhibitors iodoacetamide, KCN, NaF, and dinitrophenol, or with glutaraldehyde, or by heating at 56 degrees. Pretreatment with mitomycin C did not eliminate the stimulatory effect. PEC supernatants did not enhance tumor growth, but effector-to-target cell proximity was shown to be necessary for stimulation. PEC from tumor-immunized mice also stimulated tumor target cell growth, but to a consistently smaller degree than did nonimmune PEC. This immune inhibition correlated with in vivo survival of mice to live tumor challenge and with ability of effector cells to increase life-span in adoptive immunity tests. Differential production of thymidine by normal and immune PEC appeared not to be a factor in these assays. Fractionation of PEC showed that the immune nonadherent cells were inhibitory in vitro and were able to increase survival time in adoptive immunity tests. On the other hand, the adherent PEC from immune mice either inhibited, stimulated, or had no effect on tumor cell DNA synthesis, compared with nonimmune adherent PEC, thus exhibiting no correlation with the immune status of the donor. In one example, administration of the macrophage activator lipopolysaccharide to mice resulted in PEC that were inhibitory in the in vitro assay, although the agent did not produce in vivo immunity. The inhibition of tumor DNA synthesis assay, with unfractionated PEC, exhibited a consistent correlation with the immune status of the host when mice were sensitized to lymphoma cells. However, the variable influence of the adherent PEC population on tumor growth reduced or nullified the immune inhibitory effect in a few cases.
通过在44小时的试验中测量[3H]胸腺嘧啶核苷掺入量发现,同基因或异基因腹膜细胞(PEC)以及外周血淋巴细胞可在体外将小鼠淋巴瘤细胞的DNA合成刺激高达20倍。DNA合成的增加与培养物中肿瘤细胞数量的增加相关。贴壁的PEC群体是大部分增强作用的原因。用代谢抑制剂碘乙酰胺、氰化钾、氟化钠和二硝基苯酚,或用戊二醛预处理贴壁细胞,或在56摄氏度加热,可消除这种作用。用丝裂霉素C预处理并不能消除刺激作用。PEC上清液不能增强肿瘤生长,但已证明效应细胞与靶细胞的接近对于刺激是必要的。来自肿瘤免疫小鼠的PEC也刺激肿瘤靶细胞生长,但程度始终低于非免疫PEC。这种免疫抑制与小鼠对活肿瘤攻击的体内存活以及效应细胞在过继免疫试验中延长寿命的能力相关。在这些试验中,正常和免疫PEC中胸腺嘧啶核苷的差异产生似乎不是一个因素。PEC的分级分离表明,免疫非贴壁细胞在体外具有抑制作用,并且能够在过继免疫试验中延长存活时间。另一方面,与非免疫贴壁PEC相比,来自免疫小鼠的贴壁PEC对肿瘤细胞DNA合成要么抑制、要么刺激、要么没有影响,因此与供体的免疫状态没有相关性。在一个例子中,给小鼠施用巨噬细胞激活剂脂多糖会导致PEC在体外试验中具有抑制作用,尽管该试剂并未产生体内免疫。当小鼠对淋巴瘤细胞致敏时,用未分级的PEC进行的肿瘤DNA合成试验的抑制与宿主的免疫状态呈现一致的相关性。然而,在少数情况下,贴壁PEC群体对肿瘤生长的可变影响降低或消除了免疫抑制作用。